Loading...
XNYS
HES
Market cap41bUSD
May 29, Last price  
133.62USD
1D
1.95%
1Q
-10.29%
Jan 2017
114.51%
Name

Hess Corp

Chart & Performance

D1W1MN
P/E
14.92
P/S
3.17
EPS
8.95
Div Yield, %
1.03%
Shrs. gr., 5y
0.47%
Rev. gr., 5y
14.92%
Revenues
13.02b
+23.85%
22,747,000,00028,067,000,00031,647,000,00041,165,000,00029,569,000,00035,135,000,00038,944,000,00037,691,000,00022,284,000,00010,737,000,0006,636,000,0004,762,000,0005,466,000,0006,326,000,0006,495,000,0004,667,000,0007,473,000,00011,324,000,00010,511,000,00013,018,000,000
Net income
2.77b
+100.36%
1,242,000,0001,916,000,0001,832,000,0002,360,000,000740,000,0002,125,000,0001,703,000,0002,217,000,0005,052,000,0002,317,000,000-3,056,000,000-6,132,000,000-4,074,000,000-282,000,000-240,000,000-2,839,000,000890,000,0002,096,000,0001,382,000,0002,769,000,000
CFO
5.60b
+42.06%
1,840,000,0003,491,000,0003,507,000,0004,567,000,0003,046,000,0004,530,000,0004,984,000,0005,660,000,0004,870,000,0004,464,000,0001,981,000,000795,000,000945,000,0001,939,000,0001,642,000,0001,333,000,0002,890,000,0003,944,000,0003,942,000,0005,600,000,000
Dividend
Sep 16, 20240.5 USD/sh
Earnings
Jul 29, 2025

Profile

Apollo Healthcare Corp. is a private equity firm specializing in buyouts. It prefer to invest in founder-led businesses, carve-outs of non-core assets, industry consolidation, and growth-oriented businesses. The firm prefers to invest in private label consumer staples and aviation finance and asset management companies. It prefer to have majority stake in companies. Acasta Enterprises Inc. was founded in 2015 and is based in Toronto, Canada.
URL
https://www.hess.com/
IPO date
Mar 15, 1926
Employees
500
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
13,018,000
23.85%
10,511,000
-7.18%
11,324,000
51.53%
Cost of revenue
3,112,000
5,521,000
7,168,000
Unusual Expense (Income)
NOPBT
9,906,000
4,990,000
4,156,000
NOPBT Margin
76.09%
47.47%
36.70%
Operating Taxes
1,202,000
733,000
1,107,000
Tax Rate
12.13%
14.69%
26.64%
NOPAT
8,704,000
4,257,000
3,049,000
Net income
2,769,000
100.36%
1,382,000
-34.06%
2,096,000
135.51%
Dividends
(579,000)
(539,000)
(465,000)
Dividend yield
1.41%
1.22%
1.06%
Proceeds from repurchase of equity
(20,000)
(432,000)
BB yield
0.05%
0.98%
Debt
Debt current
369,000
1,051,000
224,000
Long-term debt
9,973,000
9,902,000
9,795,000
Deferred revenue
418,000
Other long-term liabilities
2,631,000
1,610,000
1,064,000
Net debt
9,171,000
9,265,000
7,533,000
Cash flow
Cash from operating activities
5,600,000
3,942,000
3,944,000
CAPEX
(4,946,000)
(4,108,000)
(2,725,000)
Cash from investing activities
(4,937,000)
(4,113,000)
(2,555,000)
Cash from financing activities
(1,180,000)
(627,000)
(1,106,000)
FCF
6,301,000
2,593,000
1,740,000
Balance
Cash
1,171,000
1,688,000
2,486,000
Long term investments
Excess cash
520,100
1,162,450
1,919,800
Stockholders' equity
12,003,000
3,107,000
2,290,000
Invested Capital
23,573,900
20,017,550
17,288,200
ROIC
39.93%
22.82%
18.24%
ROCE
41.11%
22.90%
21.18%
EV
Common stock shares outstanding
308,300
307,600
309,600
Price
133.01
-7.73%
144.16
1.65%
141.82
91.57%
Market cap
41,006,983
-7.52%
44,343,616
0.99%
43,907,472
91.76%
EV
50,964,983
54,224,616
52,081,472
EBITDA
12,393,000
7,183,000
5,859,000
EV/EBITDA
4.11
7.55
8.89
Interest
412,000
478,000
493,000
Interest/NOPBT
4.16%
9.58%
11.86%